Clinical Trial Update: Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating durvalumab with gemcitabine and cisplatin for high-risk resectable intrahepatic cholangiocarcinoma before surgery is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• IMFINZI (DURVALUMAB)
• Platinol (cisplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Resectable Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING